Preclinical assessment of anti-tumor activity and immune response in syngeneic tumor models

被引：0
|
作者：
Franklin, M. [1 ]
Thayer, M. [2 ]
Draper, D. [2 ]
Saims, D. [2 ]
Wise, S. [2 ]
机构：
[1] Mi Biores, Sci Dev, Ann Arbor, MI USA
[2] Mi Biores, Operat, Ann Arbor, MI USA
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 69卷
关键词：
D O I：
10.1016/S0959-8049(16)32887-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
294
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [1] Radiation enhances anti-tumor activity of immune checkpoint blockade in syngeneic tumor models
    Urs, Sumithra
    Meade, Mary Anne
    Guley, Kevin
    Krueger, Sarah
    Wong, Alden
    Wise, Scott
    Franklin, Maryland
    CANCER RESEARCH, 2018, 78 (13)
  • [2] EVALUATING THE IMPACT OF CAR DESIGN ON THE TUMOR IMMUNE MICROENVIRONMENT AND ANTI-TUMOR RESPONSE IN SYNGENEIC GLIOMA MODELS
    Haydar, Dalia
    Crawford, Jeremy
    Chou, Ching-Heng
    Guy, Cliff
    Yi, Zhongzhen
    Zoine, Jaquelyn
    Gottschalk, Stephen
    Roussel, Martine
    Thomas, Paul
    Krenciute, Giedre
    NEURO-ONCOLOGY, 2023, 25
  • [3] Combination of the angiogenesis inhibitor lucitanib with immune checkpoint blockade augments anti-tumor activity in syngeneic models
    Dusek, Rachel
    Robillard, Liliane
    Harding, Thomas
    Simmons, Andrew
    Minh Nguyen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [4] Dual immune checkpoint inhibition enhances the anti-tumor activity of trastuzumab deruxtecan in preclinical models
    Jenkins, Liam
    Kazlauskas, Laura
    Wilson, Matt
    Hammond, Scott A.
    Proia, Theresa
    Mettetal, Jerome
    CANCER RESEARCH, 2024, 84 (06)
  • [5] ANTI-TUMOR ACTIVITY OF LENTINAN IN A SYNGENEIC MURINE TUMOR-MODEL
    ROSE, WC
    REED, FC
    SIMINOFF, P
    BRADNER, WT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 192 - 192
  • [6] The immune system as anti-tumor sentinel: Molecular requirements for an anti-tumor immune response
    Markiewicz, MA
    Gajewski, TF
    CRITICAL REVIEWS IN ONCOGENESIS, 1999, 10 (03): : 247 - 260
  • [7] PASSIVE IMMUNOTHERAPHY WITH SYNGENEIC ANTI-TUMOR SERUM .3. IMMUNE-RESPONSE OF MICE IN IMMUNOTHERAPY OF TUMORS WITH SYNGENEIC ANTI-TUMOR SERUM PLUS LIPOPOLYSACCHARIDE
    SAITO, M
    YAMAZAKI, M
    MIZUNO, D
    GANN, 1978, 69 (03): : 331 - 337
  • [8] The influence of physical activity in the anti-tumor immune response in experimental breast tumor
    Bianco, Thiago M.
    Abdalla, Douglas R.
    Desiderio, Chamberttan S.
    Thys, Sofie
    Simoens, Cindy
    Bogers, John-Paul
    Murta, Eddie F. C.
    Michelin, Marcia A.
    IMMUNOLOGY LETTERS, 2017, 190 : 148 - 158
  • [9] PASSIVE IMMUNOTHERAPY WITH SYNGENEIC ANTI-TUMOR SERUM - PROTECTIVE EFFECT OF SYNGENEIC ANTI-TUMOR SERUM ON MAMMARY-TUMOR IN A SYNGENEIC HOST
    SHINODA, H
    YAMAZAKI, M
    MIZUNO, D
    GANN, 1977, 68 (05): : 561 - 565
  • [10] Inhibition of arginase in combination with radiation therapy shows increased immune-activation and anti-tumor activity in syngeneic tumor models.
    Schuller, Alwin
    Doshi, Aatman
    Cantin, Susan
    Griffin, Matt
    San Martin, Maryann
    Proia, Theresa
    Reimer, Corinne
    Mlynarski, Scott
    Finlay, Ray
    Shao, Wenlin
    CANCER RESEARCH, 2021, 81 (13)
12345